Popular topics to explore
Anupam Rasayan Q1 Net Profit Rises 14% to ₹38.7 Cr; EBITDA Up 31% YoY
ANURAS India reported consolidated net profit of ₹387 million for Q1, up from ₹340 million year-on-year.
EBITDA rose to ₹1.62 billion from ₹1.24 billion, a 31% increase, while EBITDA margin moderated slightly to 24.8% from 25.6%. The resu…
Q1FY27 Quarterly Result Announced for Anupam Rasayan India Ltd.
Q1FY27 Quarterly Result Announced for Anupam Rasayan India Ltd.
ANURAS
SEBI RA – Shubh Consultancy – Sunil Kotak – INH000015826
Specialty Chemicals company Anupam Rasayan India announced Q1FY27 results
Consolidated Financial Highlights:…
Anupam Rasayan Signs Potential ₹2,885 Crore Pact to Expand in Next-Generation Battery Chemicals
Anupam Rasayan India Ltd. has taken another strategic step in the advanced chemicals space by signing a non-binding Letter of Intent (LoI) with Spain-based BASQUEVOLT S.A. to explore the long-term supply of a speciality chemical used in sol…
Anupam Rasayan India Ltd
* Strategic EV battery chemicals deal: ANURAS has signed a Letter of Intent (LoI) with Basquevolt S.A. for the potential long-term supply of a specialty chemical product valued at ~US$300 million (≈₹2,550 crore), strengthening its presence…
ANURAS
ANUPAM RASAYAN: SIGNS LETTER OF INTENT WITH BASQUEVOLT, S.A. FOR THE POTENTIAL LONG-TERM SUPPLY OF A SPECIALTY CHEMICAL PRODUCT WORTH $300M
My View: Top 3 Developments to Watch
1. ANURAS – Global First Commercialisation of ETFA
Becoming the first company globally to commercialise ETFA using flow chemistry is a significant technological milestone.
This could strengthen Anupam Rasayan's position in high-value spec…
Stocks in news today
INFY has successfully completed and contributed to the CMMI AI Maturity (AIM) Framework and Pilot Assessment, conducted by CMMI Institute, a global leader in helping organizations reduce risk, boost performance and build capability. Throu…
BLISSGVS
Bliss GVS Pharma Limited is undergoing a major ownership transition, as Anupam Rasayan India Limited has moved to acquire a controlling stake. Anupam Rasayan has signed an agreement to purchase 43.30% of Bliss GVS from existing promoters an…
Q4FY26 & FY26 Result Announced for Anupam Rasayan India Ltd.
Q4FY26 & FY26 Result Announced for Anupam Rasayan India Ltd. ANURAS
Specialty Chemicals company Anupam Rasayan India announced Q4FY26 & FY26 results
Consolidated Financial Highlights:
Revenue from Operations: Stood at Rs 6,357.83 million…
Anupam Rasayan Expands Pharma Presence With ₹1,369 Crore Bliss GVS Deal
ANURAS will acquire up to a 43% stake in Bliss GVS Pharma for around ₹1,369 crore. The acquisition marks a major diversification step for Anupam Rasayan, which has primarily operated in specialty chemicals and custom synthesis.
The deal s…
Anupam Rasayan to Acquire 74.20% Stake in Bliss GVS Pharma for ~₹2,199 Crore
Anupam Rasayan India Ltd has approved the acquisition of up to 74.20% equity and control in Bliss GVS Pharma Limited at ₹299 per share, representing a total consideration of approximately ₹2,199 crore. Transaction Structure: Phase 1: Acqu…
Swing Bullish Strategy – Eagle Momentum (Weekly)
Swing Bullish Strategy – Eagle Momentum (Weekly)
ANURAS has been outperformed Nifty 500 over last 1 week.
The Weekly Eagle Momentum strategy focuses on identifying stocks showing strong short-term relative strength compared to the b…
ANURAS sees 31% revenue growth, 12% profit increase
Anupam Rasayan India Ltd reported a 11.6% year-on-year profit growth, increasing to ₹60.5 crore in Q3FY26 from ₹54.2 crore last year. Revenue rose 31.4% YoY to ₹512.4 crore. EBITDA margi…
Anupam Rasayan Q3: Net Profit Rises ~12% on Higher Revenue
ANURAS reported a ~12% year-on-year rise in consolidated net profit for Q3 FY26, driven by higher revenue and improved product mix. The specialty chemicals maker recorded growth in sales across key segments, supported by demand from agroch…
ANUPAM RASAYAN INDIA:
Q3 CONS NET PROFIT 490M RUPEES VS 282M (YOY) || Q3 REVENUE 5.12B RUPEES VS 3.9B (YOY)
Q3 EBITDA 1.28B RUPEES VS 1.24B (YOY) || Q3 EBITDA MARGIN 24.88% VS 31.86% (YOY)
ANURAS
14th Feb · SEBI-Registered Analyst
Stock Market with Hariom Rathor · 14th Feb
Q3 Earnings Update – February 14: PTCIL Industries, CELLO , PRECWIRE & 461 Others
Q3FY26 Results :
A total of 465 companies are set to unveil their October–December quarter earnings on February 14. Key names include PTCIL Industries, ANURAS , CELLO , KRBL L, RELIGARE , AHLUCONT Contracts India, and VIPIND Indus…
Anupam Rasayan India Ltd Luxembourg Acquisitions
ANURAS On February 12, 2026, the board ratified full acquisition of Doriath S.à r.l. (EUR 7,025, 100% stake, completed Feb 10) and 15% stake in Batam S.à r.l. (EUR 958). Doriath will acquire the "Target Group" for European expansion; agree…
🔬 Anupam Rasayan – Breakout From Long Base With Specialty Tailwinds
On the weekly chart, ANURAS is attempting a decisive breakout above the ₹1,250–1,300 zone after forming a long rounding base. Price is trading above key moving averages with improving structure.
📊 Technical View (Weekly):
Multi-month r…
ANURAS
Anupam Rasayan India Ltd’s stock has demonstrated strong momentum by reaching a new 52-week high of Rs 1379 on 11 Feb 2026. The stock’s outperformance relative to its sector and the broader market, combined with robust quarterly financial r…
ANURAS
Anupam Rasayan India Limited conducted a postal ballot through remote e-voting from December 11, 2025, to January 9, 2026, to approve three special resolutions: increasing borrowing limits under Section 180(1)(c) of the Companies Act, 2013;…
